Просмотр вакансии

Уважаемые доктора, нам нужны доктора с очень хорошим английским (С1) , если у Вас слабый английский, пожалуйста не тратьте наше время. Прочитайте внимательно требованию внизу

Responsibilities

- Adjudicate the clinical validity, mechanism, and severity of food–drug / food–disease interactions. .

- Verify each assertion against primary sources — peer-reviewed studies, guidelines, pharmacology references

- Author and revise structured clinical entries to a consistent evidentiary standard

- Grade the strength of evidence and escalate clinical uncertainty

- Collaborate with reviewers, US-licensed physicians, and the engineering team

Required

- Medical degree — NUSOM graduate, or graduate of another medical school with a preparing or passed USMLE Step 1

- Strong command of clinical pharmacology and pathophysiology

- Ability to read and critically appraise English-language scientific literature (English is the working language)

- Rigorous, evidence-based reasoning and meticulous attention to detail

-Preferred Clinical experience (internal medicine, cardiology, nephrology, clinical pharmacology, nutrition) USMLE Step 2 CK completed or in progress

- Familiarity with medical databases, guidelines, or systematic reviews Interest in clinical informatics or health technology

- Direct collaboration with US-licensed physicians and exposure to US clinical standards

- Well suited to staying clinically sharp while preparing for USMLE Step 2 / residency

About us:

MDietHealth is a US (Delaware) digital health company building a clinical decision support platform for US hospitals. We're hiring a physician as a clinical reviewer — the clinical authority validating interaction content against primary evidence before it reaches the platform. Especially for NUSOM graduates or physicians who preparing or passed USMLE Step 1.

Please kindly attach your USMLE score or notes, if you are not from NUSOM, otherwise your request will be rejected

100% office presence mandatory. Doctors from other cities and Kyrgyztan, Uzbekistan, Russia,and etc are welcome